Merck KGaA Sees Coronavirus Impact Subsiding In Q2
As Mavenclad Sales Keep Climbing
Executive Summary
The German company is exposed to events in China across its three divisions - healthcare, life sciences and performance materials - but says that COVID-19 should only affect 2020 sales by 1%, unless a global recession happens.